Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06251388
Status:
RECRUITING
Last Update Posted:
2024-02-09
First Post:
2024-01-26
Brief Title:
A Study of Concurrent Chemoradiotherapy Followed by CadonilimabAK104 for Newly Diagnosed Local Advanced Cervical Cancer
Sponsor:
West China Second University Hospital
Organization:
West China Second University Hospital
Study Overview
Official Title:
A Prospective Single Arm Multicenter Phase II Study to Evaluate the Efficacy and Safety of Concurrent Chemoradiotherapy Followed by CadonilimabAK104 for Newly Diagnosed Local Advanced Cervical Cancer
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the efficacy and safety of concurrent chemoradiotherapyCCRTfollowed by cadonilimabAK104 in high risk local advanced cervical cancer
Participants received CCRTefficacy evaluation of CCRT was no disease progression who maintained with AK104100 mgkgQ3Wuntil drug exposure over 1 years or disease progression or intolerable toxicity
Participants received CCRTefficacy evaluation of CCRT was no disease progression who maintained with AK104100 mgkgQ3Wuntil drug exposure over 1 years or disease progression or intolerable toxicity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None